Teratogenesis and maternal progesterone.
D000015:Abnormalities, Multiple / Q000139:chemically induced*; D000022:Abortion, Spontaneous / Q000517:prevention & control; D004394:Dydrogesterone / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006908:Hydroxyprogesterones / Q000009:adverse effects* / Q000627:therapeutic use; D007223:Infant; D011247:Pregnancy; D013723:Teratogens; D014551:Urinary Tract / Q000002:abnormalities*; D014621:Vagina / Q000002:abnormalities*
D006908:Hydroxyprogesterones; D013723:Teratogens; D004394:Dydrogesterone